I’m a Biohacker, But I Don’t Trust These Longevity Drugs
BulletproofPublished on September 1, 2026
Summary authored by editor@wellifi.com
TLDR Summary
Dave Asprey discusses the role of various pharmaceuticals in longevity, recommending certain drugs like tadalafil and SGLT2 inhibitors while advising against metformin, rapamycin, and statins due to adverse effects. He emphasizes the importance of combining these medications with fundamental health practices for optimal aging support.
Key Points
- Aging is influenced by numerous factors, and various pharmaceuticals can impact longevity.
- Metformin, rapamycin, and statins are not recommended for longevity due to their adverse effects.
- Pharmaceuticals like tadalafil, SGLT2 inhibitors, acarbose, and low-dose naltrexone can be beneficial for longevity.
- Pharmaceuticals should complement, not replace, fundamental health practices.
Exploring Pharmaceuticals for Longevity: Insights from Dave Asprey
In today's health and wellness landscape, understanding the intricacies of aging and the potential interventions available is crucial. Renowned biohacker Dave Asprey shares his insights on various pharmaceuticals and their roles in longevity, highlighting both what he recommends and what he advises against.
The Aging Process and Pharmaceuticals
Aging is a complex process influenced by numerous factors, including genetics, lifestyle, and environmental conditions. With about a dozen known causes of aging, Asprey emphasizes the importance of exploring various compounds, including pharmaceuticals, that can affect longevity. While some medications were developed for specific diseases, they can also impact aging pathways.
Pharmaceuticals: The No List
Asprey outlines several pharmaceuticals that he does not recommend for longevity:
- Metformin: While it is the most prescribed diabetes drug globally and can be effective for those with diabetes, Asprey argues that it blunts exercise benefits and can lead to B12 deficiency.
- Rapamycin: Initially used as an antifungal, its immunosuppressive properties can hinder growth and repair processes essential for longevity, leading to undesirable side effects.
- Statins: Although popular for cholesterol management, the harm reduction ratio is low, and Asprey points out that most individuals experience side effects without significant benefits for longevity.
Pharmaceuticals: The Yes List
Asprey presents a list of pharmaceuticals that he believes can be beneficial for longevity:
- Tadalafil (Cialis): Taken at a low dose, it enhances blood flow throughout the body, which can be beneficial for brain health.
- SGLT2 Inhibitors: Originally diabetes medications, they show promise in reducing heart failure hospitalization and improving overall metabolic health.
- Acarbose: This medication slows carbohydrate absorption in the gut, leading to lower blood sugar spikes and potential longevity benefits.
- Low-Dose Naltrexone (LDN): Known for its immune-modulating effects, LDN can help regulate inflammation and support overall health.
Addressing the Science Behind Pharmaceuticals
Asprey emphasizes that every drug mentioned was designed for a specific disease, not aging itself. The concept of repurposing these medications for longevity is based on their ability to influence critical biological pathways.
While pharmaceuticals can play a role in a comprehensive longevity strategy, they should not replace fundamental health practices such as proper nutrition, exercise, and sleep. Asprey advocates for a balanced approach that incorporates both lifestyle changes and scientifically-backed pharmaceutical interventions.
Key Takeaways
- Aging is influenced by numerous factors, and various pharmaceuticals can impact longevity.
- Metformin, rapamycin, and statins are not recommended for longevity due to their adverse effects.
- Pharmaceuticals like tadalafil, SGLT2 inhibitors, acarbose, and low-dose naltrexone can be beneficial for longevity.
- Pharmaceuticals should complement, not replace, fundamental health practices.
Conclusion
As the quest for longevity continues, understanding the role of both lifestyle choices and pharmaceuticals is essential. Dave Asprey encourages individuals to explore the potential of repurposed drugs while remaining grounded in fundamental health practices. As more research emerges, it will be crucial to adapt and refine our approaches to aging and wellness.